Atlas Trials

Advanced Malignancy

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Malignancy

RecordFirmDate
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies (NCT02978482)AstraZeneca2016-12-01
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors (NCT02743637)SynDevRx, Inc.2016-02-01
Safety Study of AMG 228 to Treat Solid Tumors (NCT02437916)Amgen2015-04-21
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma (NCT02110355)Kartos Therapeutics, Inc.2014-12-19
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia (NCT02016729)Kartos Therapeutics, Inc.2014-04-01
A Study of Anlotinib in Subjects With Advanced Malignancy (NCT04216082)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2013-08-01
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma (NCT01723020)Kartos Therapeutics, Inc.2012-12-27
Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation (NCT01558817)University of Vermont2012-02-01
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347)NantCell, Inc.2011-04-07
A Study of AMG 337 in Subjects With Advanced Solid Tumors (NCT01253707)Amgen2010-12-08
XL999 Administered Intravenously to a Subject With Advanced Malignancies (NCT01945164)John Sarantopoulos2010-04-01
A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies (NCT00978926)National University Hospital, Singapore2009-09-01
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors (NCT00858377)Amgen2009-08-10
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors (NCT00813384)Amgen2008-12-01
A Study of AMG 820 in Subjects With Advanced Solid Tumors (NCT01444404)AmMax Bio, Inc.2008-03-31
Bevacizumab and Bortezomib in Patients With Advanced Malignancy (NCT00428545)M.D. Anderson Cancer Center2007-01-01
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors (NCT00974896)NantCell, Inc.2006-12-01

Track Advanced Malignancy automatically

Every clearance here is in the API, with alerts when new ones post.